MA31238B1 - Formulations liquides filmogenes dermiques pour liberer un medicament sur la peau - Google Patents

Formulations liquides filmogenes dermiques pour liberer un medicament sur la peau

Info

Publication number
MA31238B1
MA31238B1 MA32202A MA32202A MA31238B1 MA 31238 B1 MA31238 B1 MA 31238B1 MA 32202 A MA32202 A MA 32202A MA 32202 A MA32202 A MA 32202A MA 31238 B1 MA31238 B1 MA 31238B1
Authority
MA
Morocco
Prior art keywords
skin
drug
release
formation
liquid formulations
Prior art date
Application number
MA32202A
Other languages
Arabic (ar)
English (en)
Inventor
Federico Mailland
Michela Legora
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38171596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA31238(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of MA31238B1 publication Critical patent/MA31238B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention porte sur des compositions liquides contenant du chitosan, un dérivé du chitosan ou un sel physiologiquement acceptable de ceux-ci, formant un film dermique après application sur la peau, utile pour l'administration d'actifs sur la surface de la peau et dans la couche cornée.
MA32202A 2007-02-15 2009-09-04 Formulations liquides filmogenes dermiques pour liberer un medicament sur la peau MA31238B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90140507P 2007-02-15 2007-02-15
EP07102449A EP1958613A1 (fr) 2007-02-15 2007-02-15 Formulations liquides filmogènes pour la libération des médicaments sur la peau
PCT/EP2007/063869 WO2008098634A1 (fr) 2007-02-15 2007-12-13 Formulations liquides filmogènes dermiques pour libérer un médicament sur la peau

Publications (1)

Publication Number Publication Date
MA31238B1 true MA31238B1 (fr) 2010-03-01

Family

ID=38171596

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32202A MA31238B1 (fr) 2007-02-15 2009-09-04 Formulations liquides filmogenes dermiques pour liberer un medicament sur la peau

Country Status (22)

Country Link
US (1) US20100062083A1 (fr)
EP (2) EP1958613A1 (fr)
JP (1) JP5376372B2 (fr)
KR (1) KR20090119878A (fr)
CN (2) CN101641082A (fr)
AR (1) AR065318A1 (fr)
BR (1) BRPI0721305A2 (fr)
CA (1) CA2675568C (fr)
CL (1) CL2008000442A1 (fr)
CO (1) CO6210803A2 (fr)
EA (1) EA019102B1 (fr)
EC (1) ECSP099635A (fr)
IL (2) IL199841A (fr)
MA (1) MA31238B1 (fr)
ME (1) ME00829B (fr)
MX (1) MX2009008515A (fr)
MY (1) MY161895A (fr)
NO (1) NO20092998L (fr)
NZ (1) NZ578611A (fr)
UA (1) UA97134C2 (fr)
WO (1) WO2008098634A1 (fr)
ZA (1) ZA200904945B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064833A1 (fr) 2003-01-24 2004-08-05 Connetics Australia Pty Ltd. Mousse de phosphate de clindamycine
EP2153836A1 (fr) * 2008-08-04 2010-02-17 Polichem S.A. Formules liquides formant un film pour libération de médicament dans les cheveux et sur le cuir chevelu
EP2116237A1 (fr) * 2008-08-05 2009-11-11 Polichem SA Compositions pour traiter la rosacée comprenants du chitosane et un acide dicarboxylique
WO2010096868A1 (fr) 2009-02-25 2010-09-02 Stiefel Research Australia Pty Ltd Composition de mousse à usage topique
CA2760554A1 (fr) 2009-05-01 2010-11-04 Signal Investment And Management Co. Composition antimicrobienne hydratante
WO2011024168A2 (fr) * 2009-08-26 2011-03-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd Systèmes de délivrance à libération prolongée pour la prévention et le traitement de cancers de la tête et du cou
US9364485B2 (en) * 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
KR20150043548A (ko) 2009-10-01 2015-04-22 앱탈리스 파마테크, 인코포레이티드 경구 투여용 코르티코스테로이드 조성물
US10391059B2 (en) 2009-11-11 2019-08-27 Rapamycin Holdings, Inc. Oral rapamycin nanoparticle preparations and use
GB2477768A (en) * 2010-02-12 2011-08-17 Chao-Ho Liu Pharmaceutical material for treating psoriasis
CA2816872C (fr) * 2010-11-04 2019-02-12 442 Ventures, Llc Composition et procede pour le traitement d'etats cutanes
CN102210746B (zh) * 2011-04-08 2012-11-07 福建美菰林生物科技有限公司 治疗足部真菌感染的乳膏药物组合物及其制备方法
EP2808030A4 (fr) * 2011-11-22 2015-06-03 Univ Dongguk Ind Acad Coop Composition pour prévenir, traiter ou soulager la dermatite atopique, comprenant un immunosuppresseur et un inhibiteur de la transglutaminase 2
EP2793833B1 (fr) * 2011-12-20 2020-06-24 Vyome Therapeutics Limited Compositions d'huile à usage topique pour le traitement des infections fongiques
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
WO2015034678A2 (fr) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticostéroïde contenant des compositions de comprimés se désintégrant par voie orale pour œsophagite à éonisophiles
CN106551931A (zh) * 2016-04-11 2017-04-05 张梦兮 1-羟基-2-吡啶酮类化合物在制备口腔黏膜疾病治疗药物上的用途
JP6660258B2 (ja) * 2016-06-20 2020-03-11 ライオン株式会社 制汗剤組成物
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
US12691128B2 (en) 2019-10-01 2026-07-28 Ellodi Pharmaceuticals, L.P. Methods of treating eosinophilic esophagitis and reducing candidiasis
JP7878624B2 (ja) * 2021-02-19 2026-06-23 アース製薬株式会社 噴霧された粒子の収縮を抑制する方法
CN120478204B (zh) * 2025-06-20 2026-02-17 诺德溯源(广州)生物科技有限公司 一种缓解须后刺激的舒缓修护组合物及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1170188A (en) * 1967-09-15 1969-11-12 Bayer Ag N-trityl-imidazoles and salts and uses thereof
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
DE3421363A1 (de) * 1984-06-08 1985-12-12 Bayer Ag, 5090 Leverkusen Verfahren und vorrichtung zum kontinuierlichen herstellen von gegenstaenden oder beschichtungen mit kompliziert geformten konturen
US4822604A (en) * 1985-05-20 1989-04-18 S. C. Johnson & Son, Inc. Local treatment of dandruff, seborrheic dermatitis, and psoriasis
DE3541305A1 (de) * 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
AU643058B2 (en) * 1990-08-30 1993-11-04 Terumo Kabushiki Kaisha Wound-covering materials
JPH0543480A (ja) * 1991-08-08 1993-02-23 Nippon Soda Co Ltd 活性ペプタイド含有キトサン誘導体フイルム剤
JPH05339152A (ja) * 1992-06-09 1993-12-21 Nippon Soda Co Ltd 皮膚病変局所投与薬剤含有キトサン誘導体フィルム剤
GB9411530D0 (en) * 1994-06-09 1994-08-03 Quayle Rachel A Use of polymers as film-forming barrier materials
SE9402531L (sv) * 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
EP1179352A1 (fr) * 2000-08-08 2002-02-13 MONTERESEARCH S.r.l. Composition topique pour recouvrir des lésions de la peau
EP1357873A4 (fr) * 2001-01-09 2009-09-09 Israel Dvoretzky Composition filmogene therapeutique et systeme de traitement pour cette derniere
US7297343B2 (en) * 2001-07-31 2007-11-20 Biosurface Engineering Technologies, Inc. Bioactive medical films
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
EP1491202A1 (fr) * 2003-06-23 2004-12-29 Polichem S.A. Compositions pour l'application à la surface d'ongles pour les réstructurer
JP2005281654A (ja) * 2004-03-31 2005-10-13 Rikogaku Shinkokai 温度応答性組成物およびそのヒドロゲル

Also Published As

Publication number Publication date
BRPI0721305A2 (pt) 2014-03-25
CN103751790A (zh) 2014-04-30
AR065318A1 (es) 2009-05-27
WO2008098634A1 (fr) 2008-08-21
CN101641082A (zh) 2010-02-03
ZA200904945B (en) 2010-09-29
NO20092998L (no) 2009-09-14
UA97134C2 (ru) 2012-01-10
JP2010518130A (ja) 2010-05-27
ECSP099635A (es) 2010-03-31
MY161895A (en) 2017-05-15
EA019102B1 (ru) 2014-01-30
IL199841A0 (en) 2010-04-15
US20100062083A1 (en) 2010-03-11
KR20090119878A (ko) 2009-11-20
CO6210803A2 (es) 2010-10-20
CL2008000442A1 (es) 2008-08-22
EP1958613A1 (fr) 2008-08-20
IL241166A0 (en) 2015-11-30
CA2675568C (fr) 2015-05-12
MX2009008515A (es) 2009-08-20
AU2007346756A2 (en) 2009-09-24
NZ578611A (en) 2012-08-31
AU2007346756A1 (en) 2008-08-21
EA200901112A1 (ru) 2010-02-26
EP2117500A1 (fr) 2009-11-18
IL199841A (en) 2015-09-24
CA2675568A1 (fr) 2008-08-21
JP5376372B2 (ja) 2013-12-25
ME00829B (fr) 2012-03-20

Similar Documents

Publication Publication Date Title
MY161895A (en) Dermal film-forming liquid formulations for drug release to skin
MA32600B1 (fr) Formulations liquides filmogenes pour la liberation d'un medicament sur les cheveux et le cuir chevelu
EP2301560A4 (fr) Agent pharmaceutique pour favoriser la régénération fonctionnelle d'un tissu lésé
EP2481394A4 (fr) Produit cosmétique pour la peau sous forme d'émulsion du type eau dans huile
WO2008039737A3 (fr) Procédé destiné à administrer un produit en film contenant un médicament
WO2007102243A1 (fr) Composition pharmaceutique externe
EP2203151A4 (fr) Utilisation d'inhibiteurs de la biosynthèse de la mélanine provenant de ginseng coréen et la composition cosmétique les comprenant pour le blanchiment de la peau
JP2012506417A5 (fr)
PE20090625A1 (es) Composicion farmaceutica que contiene buprenorfina y nalmefeno
EP2436369A4 (fr) Préparation cosmétique d'émulsion huile dans eau pour un soin cutané
EP1746114A4 (fr) Epaississeur soluble dans l'eau et preparation cosmetique contenant ledit produit
FR2846555A1 (fr) Nouvelle compositions dermatologiques et/ou cosmetologiques hydratantes et anti-irritantes
WO2008152260A3 (fr) Nouveaux ligands agonistes des recepteurs rars, utilisation en medecine humaine ainsi qu'en cosmetique
FR2859625B1 (fr) Contenant souple pour la preparation extemporanee et l'administration d'un produit liquide notamment un solute a usage de medicament
FR2924345B1 (fr) Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
RU2011143735A (ru) Средство для отбеливания кожи и косметический способ отбеливания кожи
FR2904556B1 (fr) Utilisation d'un extrait de pois en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
EP2349254A4 (fr) Composition externe pour la peau contenant des dérivés d'ortho-dihydroxyisoflavone et pouvant empêcher l'hyperprolifération épidermique et atténuer les affections cutanées inflammatoires
WO2025189162A1 (fr) Administration topique d'épinéphrine et de compositions de promédicaments
DE602006001401D1 (de) Kosmetisches abgabesystem und verfahren zu seiner herstellung
MA28485B1 (fr) Formulations de solutions pharmaceutiques stables pour aerosols-doseurs pressurises
TN2011000042A1 (en) Film-forming liquid formulations for drug release to hair and scalp
EP2186875A3 (fr) Préparation cosmétique ou de toilette
Desai et al. A Review: Bioadhesive Buccal Drug Delivery System and Its Significance
WO2007039821A3 (fr) Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine et dans des cosmetiques